MX2010008293A - Metodos para tratar la piel con ingredientes aromaticos activos en la piel. - Google Patents
Metodos para tratar la piel con ingredientes aromaticos activos en la piel.Info
- Publication number
- MX2010008293A MX2010008293A MX2010008293A MX2010008293A MX2010008293A MX 2010008293 A MX2010008293 A MX 2010008293A MX 2010008293 A MX2010008293 A MX 2010008293A MX 2010008293 A MX2010008293 A MX 2010008293A MX 2010008293 A MX2010008293 A MX 2010008293A
- Authority
- MX
- Mexico
- Prior art keywords
- skin
- reduces
- cell
- methods
- active ingredients
- Prior art date
Links
- 125000003118 aryl group Chemical group 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title 1
- 210000004927 skin cell Anatomy 0.000 abstract 5
- 210000003491 skin Anatomy 0.000 abstract 4
- 230000000694 effects Effects 0.000 abstract 3
- 102000003820 Lipoxygenases Human genes 0.000 abstract 2
- 108090000128 Lipoxygenases Proteins 0.000 abstract 2
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 abstract 2
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 abstract 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 abstract 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 abstract 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 1
- 102100040247 Tumor necrosis factor Human genes 0.000 abstract 1
- 206010054094 Tumour necrosis Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000004792 oxidative damage Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describe un método para tratar la piel, que reduce el daño oxidante a una célula de la piel, que reduce la actividad de lipoxigenasa (LO) en una célula de la piel, que reduce la actividad de ciclooxigenasa (COX) en una célula de la piel, que reduce el factor-a de necrosis tumoral (TNF-a) en una célula de la piel, o que reduce la actividad de la enzima metaloproteinasa de matriz en una célula de la piel, que comprende poner en contacto la piel o una célula de la piel con un ingrediente aromático activo en la piel.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2563108P | 2008-02-01 | 2008-02-01 | |
| US12/105,957 US20090197939A1 (en) | 2008-02-01 | 2008-04-18 | Methods of treating skin with aromatic skin-active ingredients |
| PCT/US2009/032430 WO2009099890A2 (en) | 2008-02-01 | 2009-01-29 | Methods of treating skin with aromatic skin-active ingredients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010008293A true MX2010008293A (es) | 2011-03-15 |
Family
ID=40932318
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013001686A MX360399B (es) | 2008-02-01 | 2009-01-29 | Metodos para tratar la piel con ingredientes aromaticos activos en la piel. |
| MX2010008293A MX2010008293A (es) | 2008-02-01 | 2009-01-29 | Metodos para tratar la piel con ingredientes aromaticos activos en la piel. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013001686A MX360399B (es) | 2008-02-01 | 2009-01-29 | Metodos para tratar la piel con ingredientes aromaticos activos en la piel. |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20090197939A1 (es) |
| EP (1) | EP2257284B1 (es) |
| KR (1) | KR101199672B1 (es) |
| CN (2) | CN101496799B (es) |
| BR (1) | BRPI0907086B1 (es) |
| CA (1) | CA2713770C (es) |
| EA (1) | EA020293B1 (es) |
| ES (1) | ES2540743T3 (es) |
| MX (2) | MX360399B (es) |
| WO (1) | WO2009099890A2 (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9284274B2 (en) | 2005-12-07 | 2016-03-15 | Ramot At Tel-Aviv University Ltd. | Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
| US9284252B2 (en) | 2009-06-09 | 2016-03-15 | Sepal Pharma Ltd. | Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders |
| US9585823B2 (en) | 2010-01-07 | 2017-03-07 | The Gillette Company | Personal care compositions comprising a multi-active system for down regulating cytokines irritation |
| US9044429B2 (en) | 2010-01-15 | 2015-06-02 | The Gillette Company | Personal care compositions comprising a methyl naphthalenyl ketone or a derivative thereof |
| MX370253B (es) * | 2011-09-16 | 2019-12-06 | Nanocare Tech Inc | Composiciones de compuestos de jasmonato y métodos de uso de las mismas. |
| US9402794B2 (en) * | 2011-12-07 | 2016-08-02 | Mary Kay Inc. | Topical skin care formulation |
| CN104918614B (zh) * | 2012-09-28 | 2018-10-16 | 株式会社资生堂 | Vegfc产生促进剂 |
| EA032573B1 (ru) | 2014-12-30 | 2019-06-28 | Юнилевер Н.В. | Композиция для осветления кожи, содержащая 4-гексилрезорцин и иломастат |
| WO2016109779A1 (en) | 2014-12-31 | 2016-07-07 | Nanocare Technologies, Inc. | Jasmonate derivatives and compositions thereof |
| CN107613971A (zh) | 2015-04-06 | 2018-01-19 | 宾夕法尼亚大学董事会 | 用于减少、或预防或逆转哺乳动物对象中皮肤色素沉着增加的组合物和方法 |
| US20170000713A1 (en) * | 2015-06-30 | 2017-01-05 | The Gillette Company | Personal care compositions comprising a sensate |
| US9789070B2 (en) * | 2015-07-28 | 2017-10-17 | Elc Management Llc | Sheet packs for treating facial or body surfaces |
| ITUA20163604A1 (it) * | 2016-05-19 | 2017-11-19 | Giuliani Spa | Composti atti a promuovere la crescita dei capelli nell'uomo e/o a fermarne o ritardarne la caduta, e composizioni per tali usi |
| KR101702389B1 (ko) * | 2016-06-22 | 2017-02-03 | 연세대학교 산학협력단 | 이오논 또는 이의 염을 유효성분으로 함유하는 피부보습 개선, 피부각질 제거, 피부탄력 증진, 홍반 억제, 피부주름 개선 또는 피부광노화 개선 효과를 갖는 조성물 |
| CN106822067A (zh) * | 2017-01-22 | 2017-06-13 | 新乡医学院 | 治疗动脉粥样硬化的药物组合物及该药物组合物的应用 |
| KR101777992B1 (ko) * | 2017-04-03 | 2017-09-12 | 연세대학교 산학협력단 | 자스몬(Jasmone) 또는 이의 염을 유효성분으로 함유하는 피부주름 개선, 보습, 탄력증진, 각질제거, 홍반억제 또는 피부광노화 개선용 조성물 |
| KR20220048378A (ko) * | 2020-10-12 | 2022-04-19 | 주식회사 에피바이오텍 | 디하이드로퓨란-2(3h)-온 이량체를 포함하는 피부미백용 조성물 |
| WO2024232303A1 (ja) * | 2023-05-10 | 2024-11-14 | 株式会社 資生堂 | 保湿剤、皮膚バリア機能改善剤、抗炎症剤、ヒアルロン酸増加剤、及びメラニン産生抑制剤 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6461622B2 (en) * | 1994-09-07 | 2002-10-08 | Johnson & Johnson Consumer Companies, Inc. | Topical compositions |
| US6147037A (en) * | 1996-08-19 | 2000-11-14 | The Procter & Gamble Company | Fragrance delivery systems |
| US6126930A (en) * | 1997-02-13 | 2000-10-03 | The Procter & Gamble Company | Spray compositions |
| US6297211B1 (en) * | 1999-02-19 | 2001-10-02 | Givaudan Roure (International) Sa | Odorant compositions |
| JP2001207188A (ja) * | 2000-01-28 | 2001-07-31 | Pola Chem Ind Inc | 過酸化脂質消去用の香料組成物 |
| US6890894B2 (en) * | 2000-02-22 | 2005-05-10 | The Procter & Gamble Company | Fatty acids, soaps surfactant systems, and consumer products based thereon |
| US6495497B1 (en) * | 2001-09-26 | 2002-12-17 | International Flavors & Fragrances Inc. | Use of 4-ethyloctanal in perfume compositions |
| US20040137024A1 (en) * | 2002-10-29 | 2004-07-15 | L'oreal | Smoothing out wrinkles with a fragrancing composition |
| KR100962988B1 (ko) * | 2003-02-07 | 2010-06-10 | (주)아모레퍼시픽 | Ｍｕｓｋ를 함유하는 피부건조 개선용 피부외용제 조성물 |
| FR2856295B1 (fr) * | 2003-06-18 | 2008-03-28 | Jean Noel Thorel | Methode de traitement esthetique, pour lutter contre l'apparition des rides et/ou les attenuer |
| US20060084589A1 (en) * | 2004-10-20 | 2006-04-20 | Vlad Florin J | Solubilizing systems for flavors and fragrances |
| GB0425305D0 (en) | 2004-11-17 | 2004-12-15 | Givaudan Sa | Bactericidal formulations |
| TWI312687B (en) * | 2005-04-21 | 2009-08-01 | Kao Corporatio | Skin lotion and wrinkle improving agent |
| US20060263308A1 (en) * | 2005-05-17 | 2006-11-23 | Ivonne Brown | Method for improving skin radiance and luminosity |
| US7838045B2 (en) * | 2005-08-18 | 2010-11-23 | Ribnicky David M | Anti-inflammatory activity of phenethylisothiocyanate (PEITC) and the Barbarea verna seed preparation containing this compound |
| JP2007070269A (ja) | 2005-09-06 | 2007-03-22 | Kao Corp | 香料組成物及びこれを含有する外用剤 |
| DE102006035789A1 (de) * | 2006-07-28 | 2008-01-31 | Beiersdorf Ag | Kosmetische Zubereitung umfassend Folsäure und Parfumbestandteile |
| KR101234024B1 (ko) * | 2006-10-31 | 2013-02-19 | (주)아모레퍼시픽 | 백매화의 향취를 재현한 향료 조성물 |
| WO2008054067A1 (en) * | 2006-10-31 | 2008-05-08 | Amorepacific Corporation | Perfume composition for expressing the fragrance of ume flowers |
| DE102007026049A1 (de) * | 2007-05-31 | 2008-12-04 | Beiersdorf Ag | Repellentien gegen Wespen |
| EP2014273A1 (de) * | 2007-06-14 | 2009-01-14 | Symrise GmbH & Co. KG | Verwendung von Menthylmethylether und weiterer Ether zum Erzeugen eines Sauberkeits- und/oder Reinlichkeitsgefühls |
| DE102007038413A1 (de) * | 2007-08-09 | 2009-02-12 | Beiersdorf Ag | Kosmetische Emulgatorkombination |
-
2008
- 2008-04-18 US US12/105,957 patent/US20090197939A1/en not_active Abandoned
- 2008-04-18 KR KR1020080036286A patent/KR101199672B1/ko not_active Expired - Fee Related
- 2008-05-20 CN CN200810100531.2A patent/CN101496799B/zh not_active Expired - Fee Related
- 2008-05-20 CN CN201410115268.XA patent/CN103919767B/zh not_active Expired - Fee Related
-
2009
- 2009-01-29 EP EP09707381.1A patent/EP2257284B1/en not_active Not-in-force
- 2009-01-29 WO PCT/US2009/032430 patent/WO2009099890A2/en not_active Ceased
- 2009-01-29 BR BRPI0907086-9A patent/BRPI0907086B1/pt not_active IP Right Cessation
- 2009-01-29 ES ES09707381.1T patent/ES2540743T3/es active Active
- 2009-01-29 MX MX2013001686A patent/MX360399B/es unknown
- 2009-01-29 MX MX2010008293A patent/MX2010008293A/es active IP Right Grant
- 2009-01-29 CA CA2713770A patent/CA2713770C/en active Active
- 2009-01-29 EA EA201001195A patent/EA020293B1/ru not_active IP Right Cessation
-
2010
- 2010-06-09 US US12/796,820 patent/US8399521B2/en not_active Expired - Fee Related
-
2019
- 2019-06-25 US US16/451,999 patent/US12280017B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN101496799A (zh) | 2009-08-05 |
| US8399521B2 (en) | 2013-03-19 |
| BRPI0907086B1 (pt) | 2021-06-22 |
| CA2713770C (en) | 2016-09-20 |
| EA020293B1 (ru) | 2014-10-30 |
| KR20090084624A (ko) | 2009-08-05 |
| WO2009099890A3 (en) | 2009-11-05 |
| CN103919767B (zh) | 2016-03-09 |
| EP2257284A2 (en) | 2010-12-08 |
| HK1199834A1 (zh) | 2015-07-24 |
| US20090197939A1 (en) | 2009-08-06 |
| CN101496799B (zh) | 2014-04-16 |
| US20190314295A1 (en) | 2019-10-17 |
| WO2009099890A2 (en) | 2009-08-13 |
| KR101199672B1 (ko) | 2012-11-09 |
| CN103919767A (zh) | 2014-07-16 |
| ES2540743T3 (es) | 2015-07-13 |
| BRPI0907086A2 (pt) | 2020-06-16 |
| US20100249222A1 (en) | 2010-09-30 |
| US12280017B2 (en) | 2025-04-22 |
| MX360399B (es) | 2018-10-31 |
| EA201001195A1 (ru) | 2011-04-29 |
| CA2713770A1 (en) | 2009-08-13 |
| EP2257284B1 (en) | 2015-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010008293A (es) | Metodos para tratar la piel con ingredientes aromaticos activos en la piel. | |
| CL2008003653A1 (es) | Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica. | |
| CL2012001103A1 (es) | Método para reducir el nivel del polipéptido tau desacetilado en una célula, que comprende poner en contacto la célula con un agente que incrementa la actividad de un polipéptido que desacetila tau y/o un agente que disminuye la actividad de un polipéptido que acetila tau; y usos terapéuticos para tratar una tauopatía. | |
| CL2011000098A1 (es) | Uso de una betadefensina de mamifero para tratar enfermedad inflamatoria. | |
| CR9869A (es) | Compuestos activos en ppar | |
| ES2421442T3 (es) | Métodos para repeler artrópodos utilizando isolongifolenona | |
| CL2011000142A1 (es) | Composicion para el control selectivo de plagas que posee al menos dos agentes activos con una primera actividad contra una plaga objetivo seleccionada y con una segunda actividad contra un organismo no objetivo, donde la primera actividad es mucho mas grande que la segunda. | |
| MX2013002372A (es) | Metodos para recelularizar un tejido o un organo para una transplantabilidad mejorada. | |
| CR20110409A (es) | Metodos para reducir la proliferacion y viabilidad de los agentes microbianos | |
| CR10226A (es) | Combinaciones del inhibidor de ang2 y vegf | |
| CL2011002959A1 (es) | Peptoide, metodo para identificar un ligando peptoide que es especificamente reconocido por las celulas autoinmunes; y su uso contre enfermedades autoinmune. | |
| ECSP11010762A (es) | Composición tópica para el tratamiento de queratosis actínica | |
| AR082674A1 (es) | Tratamiento de diabetes con celulas precursoras pancreaticas endocrinas | |
| CL2008001462A1 (es) | Composicion farmaceutica esteril que comprende un fosfolipido; metodo para preservar una composicion farmaceutica de la contaminacion microbiana; y solucion para tratar lentes de contacto | |
| MX2013002058A (es) | Composicion de tratamiento para cabello. | |
| UY31788A (es) | Formulación farmacéutica sólida con liberación retardada | |
| CL2011000583A1 (es) | Composicion plaguicida que comprende un derivado del ácido alfa-alcoxifenil-acetico y un compuesto neonicotenoide. | |
| UY32374A (es) | Método para controlar insectos en plantas | |
| PE20121258A1 (es) | Agente y metodo de control para podredumbre blanda | |
| MX2013006059A (es) | Metodo para tratar la piel con moduladores de microarn. | |
| WO2011042902A3 (en) | Microcapsules comprising benzoyl peroxide and topical compositions comprising them | |
| CL2012003689A1 (es) | Metodo para blanquear pulpa que comprende contactar la pulpa en una solucion acuosa desde ph 2-7 con peroxidasa clasificada, una fuente de peroxido de hidrogeno y un mediador; composicion de blanqueado; y uso de dicha composicion. | |
| GT200900006A (es) | Derivados de piridazina novedosos | |
| AR083363A1 (es) | Control de malezas resistentes a trifluralina con ditiopir | |
| EA201000864A1 (ru) | Фенилоксетанильные производные |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |